Cite
HARVARD Citation
Bissonnette, R. et al. (2018). Apremilast for the treatment of moderate‐to‐severe palmoplantar psoriasis: results from a double‐blind, placebo‐controlled, randomized study. Journal of the European Academy of Dermatology and Venereology. pp. 403-410. [Online].